@FiercePharma: Something's got to give in India's pharma policy contradictions. More | Follow @FiercePharma
@EricPFierce: AmerisourceBergen injects itself into compounding industry with $2.5B deal for PharMEDium. Article | Follow @EricPFierce
@CarlyHFierce: Payers want new guidelines, more data before easing access to diabetes' CV star Jardiance. Story | Follow @CarlyHFierce
> Sanofi ($SNY) launched an authorized generic version of its own rheumatoid arthritis drug Arava (leflunomide), which blocks autoimmune antibodies to reduce symptoms but also slow down RA-related joint damage. Report
> A former Merck & Co. ($MRK) scientist is sharing the Nobel Prize in medicine for helping discover treatments for two parasitic diseases that plague the developing world. Report
> India's foreign secretary says the European Union's ban on his country's generic drugs is "unwarranted" and a obstacle to current trade talks. Report
> Alvogen bought Russian rights to five hormonal branded products from Bayer, including the hormone replacement Klimonorm and contraceptive Triquilar. Release
Medical Device News
@FierceMedDev: Cancer Genetics makes strides in $14M deal for Response Genetics. FierceDiagnostics article | Follow @FierceMedDev
@EmilyWFierce: ICYMI: Want to get a warning letter from OPDP? Omit drug risks from your promos. More from FiercePharmaMarketing | Follow @EmilyWFierce
> Baxter, Boston Sci back TVA in $15M round to ease hemodialysis vascular access. Story
> FDA orders postmarket studies from trio of duodenoscope makers as 'superbug' scare continues. Article
Biotech News
@FierceBiotech: After a $191M IPO, Adaptimmune buys a new cancer R&D outpost. More | Follow @FierceBiotech
@JohnCFierce: Sold out the Fierce London biotech conference, which is cool. Thank you, UK. Event | Follow @JohnCFierce
@DamianFierce: Yes, good fun, my hip-hop peers, but what's REALLY wack is chronic obstructive pulmonary disease. | Follow @DamianFierce
> Take the poll: Has the biotech boom come to an end? Poll
> Axovant rolls into Phase III with a risky Alzheimer's gambit. More
Drug Delivery News
> Perrigo licenses Flamel's oral suspension delivery platform to develop additional OTC meds. More
> Novel catheter designed for rectal drug delivery wins CE mark. Article
> GSK obtains rights to inhaled nanoparticles made using Liquidia's PRINT platform. News
> Genisphere snags $4M to move its 3DNA platform into the clinic. Story
> Polymer microneedles embedded with cancer drugs degrade to treat skin carcinomas. More
Pharma Manufacturing News
> AmerisourceBergen lays out $2.5B for sterile compounder PharMEDium. Article
> Baxter recalls more saline, this time for potential mold contamination. Report
> India intends to establish drug testing labs in effort to boost quality. Item
> Hospira recalls more lidocaine with rust embedded in vials. Story
> Pfizer adding jobs to Ireland plant that had been slated to close. Article
Pharma Asia News
> JHL Biotech tests the waters on Taiwan's Emerging Stock Board. Item
> Something's got to give in India's pharma policy contradictions. More
> India considers drug testing labs in each state. Report
> TPP negotiators said to reach compromise on biologics. Story
> Japanese flu vaccine makers pump up prices 50%, drawing flak as peak season hits. Article
And Finally... San Francisco's aggressive approach to HIV testing and treatment has helped clamp down on new cases in the city. Report